Details for Patent: 7,919,483
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,919,483 protect, and when does it expire?
Patent 7,919,483 protects XIMINO and SOLODYN and is included in two NDAs.
This patent has twelve patent family members in nine countries.
Summary for Patent: 7,919,483
Title: | Method for the treatment of acne |
Abstract: | A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen. |
Inventor(s): | Wortzman; Mitchell (Scottsdale, AZ), Plott; R. Todd (Briscoe, TX), Bhatia; Kuljit (Nesconset, NY), Patel; Bhiku (Chandler, AZ) |
Assignee: | Medicis Pharmaceutical Corporation (Scottsdale, AZ) |
Application Number: | 11/166,817 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,919,483 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Delivery; |
Drugs Protected by US Patent 7,919,483
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | RX | No | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF ACNE | See Plans and Pricing | ||||
Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | RX | No | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF ACNE | See Plans and Pricing | ||||
Journey | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF ACNE | See Plans and Pricing | ||||
Bausch | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-001 | May 8, 2006 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | TREATMENT OF ACNE | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,919,483
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006262428 | See Plans and Pricing | |||
Canada | 2613273 | See Plans and Pricing | |||
China | 101208097 | See Plans and Pricing | |||
European Patent Office | 1898925 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |